Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of the Butantan Institute Trivalent Seasonal Influenza Vaccine in Comparison With the Sanofi Pasteur Trivalent Seasonal Influenza Vaccine in Brazilian Subjects.

NCT03777163 is registered in ClinicalTrials.gov with Butantan Institute as lead sponsor.

NCT NCT03777163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03777163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of the Butantan Institute Trivalent Seasonal Influenza Vaccine in Comparison With the Sanofi Pasteur Trivalent Seasonal Influenza Vaccine in Brazilian Subjects.
Lead sponsor
Butantan Institute
Phase
Phase 4
Overall status
Completed
Start date
April 22, 2019
Completion date
March 30, 2020
Enrollment
632 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

influenza